https://nova.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens. https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41071 20% in TC and TCH inroutine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 10 Jan 2024 11:15:37 AEDT ]]> A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51107 20% in TC and TCH in routine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 04 Oct 2023 11:54:27 AEDT ]]> Guideline for the management of fever and neutropenia in children with cancer and/or undergoing hematopoietic stem-cell transplantation https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:22368 Sat 24 Mar 2018 07:09:30 AEDT ]]> Continuation of treatment with clozapine after an episode of neutropenia https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46272 Mon 14 Nov 2022 15:14:08 AEDT ]]>